
What is Mounjaro and who is it for?
Mounjaro (tirzepatide) is a prescription medicine made by Eli Lilly for type 2 diabetes. It is FDA-approved to:
Improve blood sugar: with diet and exercise, in adults and children 10 and older with type 2 diabetes.
Protect the heart: reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for them.

Mounjaro or Zepbound?
Mounjaro and Zepbound both contain tirzepatide, and both come in weekly doses from 2.5 mg to 15 mg.
Mounjaro is approved for type 2 diabetes.
Zepbound is approved for weight management in adults with obesity, or overweight and a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.
Your insurance plan decides coverage for each one by its own rules. We sort that out before your first visit. Read about Zepbound.

How Mounjaro works
Tirzepatide acts like two hormones your gut releases after you eat, GIP and GLP-1.
Steadies blood sugar: it helps your body release insulin when blood sugar rises.
Quiets hunger: it signals your brain that you have had enough.
Keeps you full longer: food leaves your stomach more slowly.
Taking it safely
Mounjaro is a once-weekly injection under the skin, at any time of day, with or without food. Your physician starts at 2.5 mg and raises the dose step by step, and your care team shows you how to inject.
Most side effects are stomach-related and ease as your body adjusts. Mounjaro is not right for everyone, so your physician goes through your health history with you first. The details from the FDA label are below.
Dosing steps
- The label starts at 2.5 mg once a week.
- After at least 4 weeks on a dose, it can go up by 2.5 mg if more blood sugar control is needed.
- The highest dose is 15 mg a week for adults and 10 mg a week for children 10 and older.
Common side effects
- The most common side effects are nausea, diarrhea, less appetite, vomiting, constipation, indigestion and stomach pain.
- They are most likely when you start or raise the dose, and they often ease as your body adjusts.
Boxed warning
- In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid cancer, in people.
- Tell your physician right away about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Who should not take it
- Tirzepatide is not for you if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).
- It is also not for anyone who has had a serious allergic reaction to tirzepatide or to anything in the medicine.
- If you are pregnant or planning a pregnancy, tell your physician.
Less common but serious
- Problems listed on the label include inflammation of the pancreas, low blood sugar with insulin or a sulfonylurea, serious allergic reactions, kidney problems from losing fluid, severe stomach problems, eye changes in people with diabetic eye disease and gallbladder problems.
- Never share a Mounjaro KwikPen with anyone, even if the needle is changed.
- Tell your care team before any surgery or sedation: GLP-1 medicines can raise the risk of food getting into the lungs during anesthesia.
What Mounjaro costs
With insurance: coverage depends on your plan. We check it before your first visit, submit any prior authorization for you and handle appeals if needed. Read how to check your GLP-1 coverage.
Copay help: we help you use the maker's copay assistance if you have commercial insurance.
Your visits: Most major insurance accepted, plus convenient cash pay options. Visits are billed to your insurance, and you pay any copay.
Medicare: we bill Medicare for visits.
Aayu Well's own self-pay plans are for compounded semaglutide and compounded tirzepatide. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. They are not the same as Mounjaro or any brand-name medicine. Read about tirzepatide options.
How Aayu Well helps
Insurance checked first: we look at your coverage before your first visit, so you know your options before you decide.
Prior authorization handled: our team prepares and submits it for brand-name medicine as a concierge service, and handles appeals if your plan says no.
Copay help: if you have commercial insurance, we help you use the maker's copay assistance.
A physician who knows you: Darshan Patel, MD, an obesity medicine physician, sees you by video or in person in Deer Park, Illinois, and adjusts your dose with you.
A registered dietitian: help with meals that fit your new appetite, protein on a GLP-1 and keeping your muscle.
A care team between visits: message us about side effects, doses or refills, and hear back from people who know your plan.
A plan for the long run: Do I have to take a GLP-1 forever?
We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin.














